What is MoonLake Immunotherapeutics's investing cash flow?

MoonLake Immunotherapeutics (MLTX) reported investing cash flow of $98K in Q1 2026.

How has MoonLake Immunotherapeutics's investing cash flow changed year-over-year?

MoonLake Immunotherapeutics's investing cash flow decreased by 99.8% year-over-year, from $56.25M to $98K.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

MoonLake Immunotherapeutics MLTX Investing Cash Flow

Investing Cash Flow at other companies

Eli LillyLLY

-$3.92B-16.8%

Oruka Therapeutics, Inc.ORKA

-$14.44M-134%

AnaptysBio, Inc.ANAB

$34.98M+136%

Opko HealthOPK

-$1.8M-104%

Cullinan Therapeutics, Inc.CGEM

$32.41M-11.9%

Nektar TherapeuticsNKTR

-$350.79M-903%

Other financials

Income statement

See full

Operating income-$70.0M-47.5%

Net income-$69.7M-74.5%

EPS (diluted)-$0.98-55.6%

Balance sheet

See full

Cash & equivalents$298.5M+9.9%

Total debt$100.8M+33.3%

Total equity$254.0M-37.7%

Total assets$400.4M-21.7%

Cash flow

See full

Operating cash flow-$66.3M-73.8%

CapEx--100%

Free cash flow-$66.3M-73.6%

Valuation

See full

Market cap$1.49B-45.9%

Enterprise value$1.29B-50.0%

Returns & leverage

See full

Return on equity-77.7%-221pp

Debt / equity0.4×+0.2×

Current ratio8.6×-12.5×

Where this comes from

Reported directly by MoonLake Immunotherapeutics in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about MoonLake Immunotherapeutics's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MoonLake Immunotherapeutics's investing cash flow?: MoonLake Immunotherapeutics (MLTX) reported investing cash flow of $98K in Q1 2026.
How has MoonLake Immunotherapeutics's investing cash flow changed year-over-year?: MoonLake Immunotherapeutics's investing cash flow decreased by 99.8% year-over-year, from $56.25M to $98K.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.